A Study Of Endorail In Assisting Difficult Colonoscopies

Overview

About this study

To purpose of this study is to evaluate the safety and efficacy of Endorail in facilitating completion of colonoscopy in patients with difficult procedures.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults aged 18-80 years.

  • Scheduled for elective colonoscopy (diagnostic, screening, and surveillance)

  • Informed consent provided.

  • Failure to reach the cecum within 15 minutes during the colonoscopy procedure.

Exclusion Criteria:

  • Colonic obstruction or stricture.

  • Severe comorbidities that contraindicate colonoscopy.

  • Pregnant or lactating women.

  • Patients unable to provide informed consent.

  • Any contraindication to Endorail including any diverticular disease associated with narrowing of the colon or active diverticulitis.

  • BMI>30 without transillumination

  • BBPS<2 in any colon segment

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/01/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Michael Wallace, M.D.

Contact us for the latest status

Contact information:

Clinical Studies Unit - Florida

(904) 953-2255

More information

Publications

Publications are currently not available